BANK OF AMERICA CORP /DE/ - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,554,558
-83.7%
170,456
-81.1%
0.00%
-100.0%
Q2 2023$9,535,204
+54.0%
901,248
+78.0%
0.00%0.0%
Q1 2023$6,190,874
+92.1%
506,204
+94.9%
0.00%
Q4 2022$3,222,727
-9.1%
259,688
+0.1%
0.00%
Q3 2022$3,544,000
+87.7%
259,449
+151.9%
0.00%
Q2 2022$1,888,000
-52.8%
103,009
-58.6%
0.00%
Q1 2022$3,997,000
-2.8%
248,557
-15.4%
0.00%
Q4 2021$4,112,000
+170.9%
293,697
+262.2%
0.00%
Q3 2021$1,518,000
-5.1%
81,079
+5.7%
0.00%
Q2 2021$1,600,000
-31.3%
76,738
-6.9%
0.00%
Q1 2021$2,329,000
-6.1%
82,415
+8.5%
0.00%
Q4 2020$2,481,000
+1.8%
75,981
-4.5%
0.00%
Q3 2020$2,437,000
+67.8%
79,527
-10.7%
0.00%
Q2 2020$1,452,000
+76.9%
89,090
+7.9%
0.00%
Q1 2020$821,000
-28.9%
82,573
-1.5%
0.00%
Q4 2019$1,154,000
-23.2%
83,857
-15.4%
0.00%
Q3 2019$1,503,000
-36.1%
99,132
-17.0%
0.00%
Q2 2019$2,351,000
+25.7%
119,409
+5.9%
0.00%
Q1 2019$1,871,000
+65.0%
112,748
+39.5%
0.00%
Q4 2018$1,134,000
-31.0%
80,825
-13.9%
0.00%
Q3 2018$1,644,000
+409.0%
93,915
+429.7%
0.00%
Q2 2018$323,000
+314.1%
17,729
+327.1%
0.00%
Q1 2018$78,000
-27.1%
4,151
-40.3%
0.00%
Q4 2017$107,000
+723.1%
6,957
+673.9%
0.00%
Q3 2017$13,000899
+89800.0%
0.00%
Q4 2016$01
-98.4%
0.00%
Q3 2016$0
-100.0%
62
-80.0%
0.00%
Q2 2016$1,0003100.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders